Abstract
There are three groups of patients with abnormalities of magnesium homoeostasis. The first one include patients with magnesium deficiency (low total body magnesium content) and a resultant hypomagnesaemia (low serum magnesium concentration). Patients with hypomagnesaemia (serum magnesium concentration <0.75 mmol/L) in the absence of magnesium deficiency (i.e., a normal total body magnesium content) consist the second group. The third group include patients with magnesium deficiency (low total body magnesium content) but no evidence of hypomagnesaemia (i.e., a normal serum magnesium concentration). Magnesium deficiency can be caused by decreased magnesium intake from the diet, decreased magnesium absorption, or increased renal magnesium excretion (renal magnesium wasting). The narrative review examines the causes, clinical and laboratory signs of magnesium deficiency in the body, and the effect of magnesium supplementation on health indices. Groups of people who are more likely to suffer from magnesium deficiency are outlined. Emphasis is placed on the use of questionnaires to identify individuals with possible magnesium deficiency. The changes on the electrocardiograms that are characteristic of the initial magnesium deficiency and that occur in case of its increase are given. The effect of additional intake of magnesium salts on blood pressure changes in individuals with and without baseline hypertension is discussed in detail. Factors that make it difficult to assess the relationship between magnesium intake and abnormalities in lipid and carbohydrate metabolism are listed. An association between increased dietary magnesium intake and reduced risk of certain cardiovascular diseases, diabetes mellitus, and overall mortality has been demonstrated.
Keywords: hypomagnesaemia, blood pressure, diabetes mellitus.
References
Schuchardt JP, Hahn A. Intestinal Absorption and Factors Influencing Bioavailabil-ity of Magnesium – An Update. Curr Nutr Food Sci. 2017;13:260-78. DOI: 10.2174/1573401313666170427162740. PMID: 29123461.
Franz KB. A Functional Biological Marker Is Needed for Diagnosing Magnesium Deficiency. J Am Coll Nutr. 2004;23:738S-41S. DOI: 10.1080/07315724.2004.10719418. PMID: 15637224.
Wester PO. Magnesium. Am J Clin Nutr. 1987;45(5 Suppl):1305-12. DOI: 10.1093/ajcn/45.5.1305. PMID: 3578120.
Tinawi M. Disorders of Magnesium Metabolism: Hypomagnesemia and Hyper-magnesemia. Arch. Clin. Biomed. Res. 2020;4:205-20.
Romani AM, Scarpa A. Regulation of Cellular Magnesium. Front Biosci. 2000;5: D720-34. DOI: 10.2741/romani. PMID: 10922296.
Wang HW, Huang YT, Jiang MY. Association of dietary magnesium intake and gly-cohemoglobin with mortality risk in diabetic patients. PLoS One. 2022;17:e0277180. DOI: 10.1371/journal.pone.0277180. PMID: 36576930.
Kirkland AE, Sarlo GL, Holton KF. The Role of magnesium in neurological disor-ders. Nutrients. 2018;10:730. DOI: 10.3390/nu10060730. PMID: 29882776.
Fiorentini D, Cappadone C, Farruggia G, Prata C. Magnesium: Biochemistry, Nutri-tion, Detection, and Social Impact of Diseases Linked to Its Deficiency. Nutrients. 2021;13:1136. DOI: 10.3390/nu13041136. PMID: 33808247.
Romani AM. Magnesium Homeostasis and Alcohol Consumption. Magnes Res. 2008;21:197-204. PMID: 19271417.
Ismail AAA, Ismail Y, Ismail AA. Chronic Magnesium Deficiency and Human Disease; Time for Reappraisal? QJM. 2018;111:759–63. DOI: 10.1093/qjmed/hcx186. PMID: 29036357.
Orlova S, Dikke G, Pickering G, Konchits S, Starostin K, Bevz A. Magnesium De-ficiency Questionnaire: A New Non-Invasive Magnesium Deficiency Screening Tool Developed Using Real-World Data from Four Observational Studies. Nutrients. 2020;12:2062. DOI: 10.3390/nu12072062. PMID: 32664490.
Veronese N, Demurtas J, Pesolillo G, Celotto S, Barnini T, Calusi G, et al. Magne-sium and Health Outcomes: An Umbrella Review of Systematic Reviews and Meta-analyses of Observational and Intervention Studies. Eur J Nutr. 2020;59:263-72. DOI: 10.1007/s00394-019-01905-w. PMID: 30684032.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, AlonsoCoello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924–6. DOI: 10.1136/bmj.39489.470347.AD. PMID: 18436948.
Rosanoff A, Costello RB, Johnson GH. Effectively Prescribing Oral Magnesium Therapy for Hypertension: A Categorized Systematic Review of 49 Clinical Trials. Nutrients. 2021;13:195. DOI: 10.3390/nu13010195. PMID: 33435187.
Frojdo S, Vidal H, Pirola L. Alterations of Insulin Signaling in Type 2 Diabetes: A Review of the Current Evidence From Humans. Biochim Biophys Acta. 2009;1792:83-92. DOI: 10.1016/j.bbadis.2008.10.019. PMID: 19041393.
Kostov K. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. Int. J. Mol. Sci. 2019;20:1351. DOI: 10.3390/ijms20061351. PMID: 30889804.
Gommers LMM, Hoenderop JGJ, Bindels RJM, de Baaij JHF. Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? Diabetes. 2016;65:3-13. DOI: 10.2337/db15-1028. PMID: 26696633.
Piuri G, Zocchi M, Della Porta M, Ficara V, Manoni M, Zuccotti GV, et al. Magne-sium in Obesity, Metabolic Syndrome, and Type 2 Diabetes. Nutrients. 2021;13:320. DOI: 10.3390/nu13020320. PMID: 33499378.
Gaman M-A, Dobrica E-C, Cozma M-A, Antonie N-I, Stanescu AMA, Gaman AM, Diaconu CC. Crosstalk of Magnesium and Serum Lipids in Dyslipidemia and Associated Disorders: A Systematic Review. Nutrients. 2021;13:1411. DOI: 10.3390/nu13051411. PMID: 33922341.
Fang X, Wang K, Han D, He X, Wei J, Zhao L, et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies. BMC Med. 2016;14:210. DOI: 10.1186/s12916-016-0742-z. PMID: 27927203.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.